Selectis Health, Inc. 2025 Annual Report: Key Investor Insights and Potential Price Movers

Overview

Selectis Health, Inc. (“Selectis” or “the Company”) has released its Annual Report for the fiscal year ended December 31, 2025. This comprehensive disclosure offers significant insights for investors, including updates on the company’s business model transformation, asset sales, financial position, risk factors, and strategic direction. Several developments in this report may have material implications for the company’s share value.

Key Highlights

• Business Model Transformation: Selectis has made a significant strategic shift from leasing long-term care facilities to third-party, independent operators to an owner-operator model. This change, initiated in 2019, has altered the company’s revenue mix — moving away from rents to revenues derived from direct healthcare provision. The focus is now on operating Assisted Living, Independent Living, and Skilled Nursing Facilities across the South and Southeastern U.S.
• Major Asset Sale: In January 2026, Selectis completed the sale of two of its Georgia facilities for a total purchase price of \$13.2 million. As of February 2026, the company operates seven healthcare facilities. This transaction provides a substantial liquidity boost and may impact future revenue streams and operational focus.
• Financial Position and Capital Structure:
  • As of December 31, 2025, the company had \$325,192 outstanding on its Commercial Line of Credit, with approximately \$425,000 available for additional borrowing.
  • Selectis renegotiated its Senior Secured Notes multiple times. Most recently, the company extended the maturity to December 31, 2025, increased the interest rate to 13%, and reduced the warrant exercise price to \$2.25 per share. This may affect dilution and interest expense going forward.
  • The aggregate market value of public float as of June 30, 2025, was \$4.0 million, with 3,067,059 shares outstanding as of April 13, 2026.
• Business Strategy:
  • Focus on four pillars: quality healthcare, opportunistic investing, portfolio diversification, and conservative financing.
  • Intention to maintain a diversified portfolio by operational type, geography, operator, and product to mitigate risks.
  • Continued efforts to manage debt levels prudently, maintain liquidity, and use both short-term and long-term financing, including asset sales and capital markets activity.
• Competition: The healthcare real estate sector is highly competitive. Selectis faces competition from larger REITs, investment companies, private equity, and other institutional investors, many of which may have deeper resources and lower costs of capital. This environment may impact Selectis’ ability to identify and capitalize on attractive opportunities.
• Regulatory and ESG Focus:
  • The company operates in a tightly regulated industry, with compliance requirements from CDC, ADA, CMS, and various state and local authorities.
  • Ongoing government scrutiny of private equity involvement in skilled nursing, which could introduce additional regulatory requirements impacting future operations and profitability.
  • Selectis highlights its commitment to ESG (Environmental, Social, and Governance) initiatives and human capital management, with oversight at the board level and programs aimed at employee engagement and community involvement.

Key Risks and Price-Sensitive Issues

• Revenue Sensitivity: Selectis’ revenues and those of its tenants are highly sensitive to occupancy rates. Lower occupancy, increased mortality, or inability to attract new residents (especially in light of COVID-19 and other health crises) could materially impact revenue and cash flows.
• Operational and Acquisition Risks: Increased costs, supply chain disruptions, or regulatory changes may affect profitability. Additionally, difficulties in property acquisition, disposition, or development could negatively impact long-term competitive position.
• Liquidity and Financing Risks: Market volatility, rising interest rates, or restricted access to capital could increase borrowing costs or limit growth. There’s a risk of credit rating downgrades, which could further increase the cost of capital and reduce financial flexibility.
• Regulatory Uncertainty: Enhanced scrutiny of private equity in healthcare and changing reimbursement policies could impact margins and business strategy.
• Concentration and Diversification Strategy: While Selectis aims for diversification, the relatively small size and focus of its portfolio may subject the company to additional risk if any market or operational challenge disproportionately impacts its assets or regions.

Recent Developments with Potential Share Price Impact

• Completion of \$13.2 Million Asset Sale — This significant transaction boosts liquidity and could either be used for debt reduction, reinvestment, or further operational improvements. However, it also reduces the asset base and may affect future revenue generation unless offset by new acquisitions or operating gains.
• Modification of Senior Secured Notes (Interest Increased to 13%, Warrant Price Reduced) — These changes could impact both near-term net income (through higher interest expense) and longer-term dilution if warrants are exercised at a lower price, which may affect share value. Investors should monitor further capital structure changes and related dilution risk.
• Shift to Owner-Operator Model — This ongoing transition increases operational risk and reward, as Selectis becomes more exposed to the healthcare operating environment rather than relying on lease payments. This could increase earnings volatility but also offers upside if operations are well-managed.
• Ongoing Regulatory Scrutiny — With the Biden Administration and Congress focusing on private equity in skilled nursing, new regulations or cost burdens could arise, impacting both current earnings and future valuation multiples for the sector.
• Small Public Float — With only \$4 million in public float, the shares may be more susceptible to volatility from news, liquidity events, or block trades.

Other Notable Disclosures

• ESG and Human Capital Management: Selectis is prioritizing sustainability, employee engagement, competitive benefits, and community involvement. Oversight of these initiatives is at the board level, which may appeal to ESG-focused investors.
• Taxation: The report outlines federal income tax considerations for investors, including the impact of recent legislation such as the 3.8% net investment income tax and 2025’s “One Big Beautiful Bill Act” (OBBBA) affecting the deductibility of business interest expense.

Conclusion

Selectis Health, Inc. has undergone significant transformation in its business model, capital structure, and asset base over the past year. The completion of a major asset sale, ongoing strategic shift to an owner-operator model, renegotiations of debt, and heightened regulatory attention present both risks and opportunities for the company and its shareholders. These developments are material and could drive future share price volatility, depending on the company’s execution and external factors affecting the healthcare and real estate markets.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should review the full SEC filings and consult with their financial advisor before making investment decisions regarding Selectis Health, Inc.

View SELECTIS HEALTH, INC. Historical chart here